Abstract
The advent of accurate, noninvasive angiography has raised hopes that premorbid screening for cerebral aneurysm will soon be possible. This article discusses the medical and economic issues which will determine the appropriate conditions for, and cost-effectiveness of, large-scale aneurysm screening.
MeSH terms
-
Cerebral Angiography / economics*
-
Cost-Benefit Analysis
-
Craniotomy / economics
-
Disease Progression
-
Family Health
-
Humans
-
Intracranial Aneurysm / economics*
-
Intracranial Aneurysm / physiopathology
-
Intracranial Aneurysm / prevention & control
-
Intracranial Aneurysm / surgery
-
Mass Screening / economics*
-
Mass Screening / methods
-
Models, Economic
-
Patient Selection
-
Risk Factors
-
Subarachnoid Hemorrhage / economics*
-
Subarachnoid Hemorrhage / physiopathology
-
Subarachnoid Hemorrhage / prevention & control
-
Subarachnoid Hemorrhage / surgery
-
United States